While pioglitazone showed its anti-inflammatory effects to be reliant on AnxA1, it is known pioglitazone has other effects that are PPARγ-independent, such as induction of migration of vascular smooth muscle cells and inhibition of proliferation of tumor cells (Emery et al., 2006; Li et al., 2008). The gene discussed is PPARG; the disease is neoplasm.